Fulcrum Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $825k | 90k | 9.20 |
| 2025-06-30 | $771k | 112k | 6.88 |
| 2025-03-31 | $238k | 83k | 2.89 |
| 2024-12-31 | $575k | 122k | 4.71 |
| 2024-09-30 | $443k | 124k | 3.57 |
| 2024-06-30 | $165k | 27k | 6.21 |
| 2024-03-31 | $666k | 72k | 9.31 |
| 2023-12-31 | $460k | 68k | 6.75 |
| 2023-06-30 | $478k | 145k | 3.30 |
| 2023-03-31 | $77k | 27k | 2.84 |
| 2022-12-31 | $85k | 12k | 7.27 |
| 2022-09-30 | $12k | 1.4k | 8.29 |
| 2022-06-30 | $8.0k | 1.7k | 4.67 |
| 2022-03-31 | $554k | 23k | 23.69 |